降压降脂预防心脏病发作试验（ALLHAT）：实际意义。 - Suppr

Suppr

超能文献

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.

作者信息

Oparil Suzanne

出版信息

Hypertension. 2003 May;41(5):1006-9. doi: 10.1161/01.HYP.0000070905.09395.F6. Epub 2003 Apr 14.

DOI:10.1161/01.HYP.0000070905.09395.F6

PMID:12695423

Abstract

摘要

相似文献

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.

Hypertension. 2003 May;41(5):1006-9. doi: 10.1161/01.HYP.0000070905.09395.F6. Epub 2003 Apr 14.

[ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].

Nihon Rinsho. 2001 Mar;59 Suppl 3:393-7.

ALLHAT: setting the record straight.

Ann Intern Med. 2004 Jul 6;141(1):39-46. doi: 10.7326/0003-4819-141-1-200407060-00013.

ALLHAT, or the soft science of the secondary end point.

Ann Intern Med. 2004 Jul 6;141(1):77. doi: 10.7326/0003-4819-141-1-200407060-00023.

Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Clin Exp Hypertens. 1996 Apr-May;18(3-4):569-79. doi: 10.3109/10641969609088986.

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60. doi: 10.1016/0895-7061(96)00037-4.

Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.

ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.

Am J Hypertens. 1996 Apr;9(4 Pt 1):409-11.

Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Control Clin Trials. 2001 Dec;22(6):674-86. doi: 10.1016/s0197-2456(01)00177-5.

[Commentary on the ALLHAT study. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].

Dtsch Med Wochenschr. 2003 May 30;128(22):1252. doi: 10.1055/s-2003-39457.

引用本文的文献

Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit.

Adv Ther. 2023 Jul;40(7):2965-2984. doi: 10.1007/s12325-023-02529-7. Epub 2023 May 26.

Should Renal Inflammation Be Targeted While Treating Hypertension?

Front Physiol. 2022 Jun 13;13:886779. doi: 10.3389/fphys.2022.886779. eCollection 2022.

Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries.

Diabetes Metab Syndr Obes. 2022 Feb 16;15:451-465. doi: 10.2147/DMSO.S333787. eCollection 2022.

Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy.

F1000Res. 2017 Mar 21;6. doi: 10.12688/f1000research.9692.1. eCollection 2017.

Resistant Hypertension and Sleep Duration among Blacks with Metabolic Syndrome MetSO.

J Sleep Disord Treat Care. 2016;5(4). doi: 10.4172/2325-9639.1000183. Epub 2016 Aug 12.

Impact of the obesity epidemic on hypertension and renal disease.

Curr Hypertens Rep. 2003 Oct;5(5):386-92. doi: 10.1007/s11906-003-0084-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验